The Cartiva FDA Recall

For years, patients and surgeons reported that the Cartiva implant was failing at alarming rates. Yet, the device remained on the market. That changed in October 2024, when a Class II Device Recall was finally initiated for the Cartiva Synthetic Cartilage Implant.

What the Recall Says: The recall notice acknowledges what victims have known for years: the device has a "higher-than-expected occurrence rate" of failure.

  • Recall Date: October 31, 2024
  • Recall Class: Class II (Situation where use may cause temporary or medically reversible adverse health consequences)
  • Reason: High rates of revision, removal, implant subsidence (sinking), displacement, and pain.

Why This Matters for Your Case: A recall is a critical piece of evidence. It suggests that the manufacturer acknowledges the product is not performing as represented. If you received a Cartiva implant, your device is part of this recall.  Contact us today to discuss your options.